Sequence Bio
PrivateLast Round
VC Round
May 20, 2021
Est. Valuation
$2.14M
Total Funding Raised
$4.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sequence Bio operates in Healthcare & Life Sciences and is based in St. John's. Its latest recorded funding round was a VC Round in May 2021.
Sequence Bio is a biotechnology company that leverages the unique genetics of the Newfoundland and Labrador founder population to discover drug targets and develop medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sequence Bio Comparables
Compare Sequence Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Population Bio, Inc. | 80% | |
| HiberCell | 77% | |
| Variant Bio | 76% |
For institutional investors. Book with your work email.
Sequence Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 20, 2021 | ||||
| Accelerator | Aug 23, 2019 | ||||
| Seed | Aug 3, 2016 | ||||
| Seed | Oct 20, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sequence Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Killick Capital | Seed |
| Y Combinator | Accelerator |
| Pelorus Venture Capital | Seed |
| Klister Credit Corp. | Seed, VC Round |
| Columbus Capital | VC Round |
| DCVC (Data Collective) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 2316% MoM, from 89 to 2.2K.
- May 11, 2026
Monthly visitors increased 42% MoM.
For institutional investors. Book with your work email.
Sequence Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sequence Bio's valuation, stock price, and market status.
Is Sequence Bio a public or private company?
Sequence Bio is a private company.
What is the current stock price of Sequence Bio?
Sequence Bio is a private company, so its shares have no public market price. Caplight tracks Sequence Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sequence Bio worth (valuation)?
Sequence Bio's valuation is estimated at $2.1M based on funding round data.
Can I buy Sequence Bio stock?
Sequence Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sequence Bio's last funding round?
Sequence Bio's most recent funding round was VC Round on May 20, 2021.
Who are the main investors in Sequence Bio?
Key investors in Sequence Bio include Y Combinator, Columbus Capital, DCVC (Data Collective).
Will Sequence Bio IPO soon?
No public IPO plans have been announced for Sequence Bio.
How can I track Sequence Bio secondary market activity?
Caplight tracks bids, offers, and trades in Sequence Bio's shares on secondary markets.